Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2006-08-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting
NCT00237289
Evaluation of the Genetics of Bipolar Disorder
NCT00001174
A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
NCT00035802
Clinical Risk State for Bipolar Disorder in Adolescents
NCT01383915
Bipolar Disorder Study for Men and Women
NCT00056277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* the rate of bipolar symptoms as measured by a self-reporting screening tool in a tertiary epilepsy center setting
* the meaning of a positive screening score in epilepsy patients
* the utility, sensitivity and specificity of alternative screening tools for mood instability in epilepsy patients
* the correlation of mood instability with seizure-related variables
* the relation of a positive screening score on quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being evaluated at the Long Island Jewish Comprehensive Epilepsy Center
* Capable of completing self-reporting questionnaires
Exclusion Criteria
* Patients with pseudoseizures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sean Hwang, MD
Role: PRINCIPAL_INVESTIGATOR
Long Island Jewish Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Shore Long Island Jewish Health System
Great Neck, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06.02.029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.